Clinical application of spectral electromagnetic interaction in breast cancer

Diagnostic results of a pilot study

Concetta De Cicco, Luigi Mariani, Clarbruno Vedruccio, Carla Ricci, Massimo Balma, Nicole Rotmensz, Mahila Esmeralda Ferrari, Elena Autino, Gluseppe Trifirò, Virgilio Sacchini, Giuseppe Viale, Giovanni Paganelli

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aims and background: There is a need for a cost-effective method to safely reduce the number of diagnostic procedures women undergo for breast cancer. We tested a new procedure for breast cancer diagnosis based on breast tissue response to low level electromagnetic incident waves. Methods: We tested 101 patients with suspicious palpable breast lesions detected by mammography or ultrasonography, who were scheduled to undergo an open biopsy. Using an electromagnetic field generator (tissue resonance interaction method probe [TRIMprob™]), we passed the TRIMprob™ over the breast area and recorded the signal variation of one or more spectral lines (dB1, dB2, dB3). The results were compared with those of a control group as well as with pathology data obtained from excisional biopsy. Results: No adverse effects of the test were observed. Pathology revealed 86 malignant breast cancers (72 invasive, 14 in situ) and 15 benign conditions. We achieved the best discrimination between normal breasts and lesions using dB1 (dB1 AUC-ROC = 0.8; dB2 AUC-ROC = 0.61; dB3 AUC-ROC = 0.76). With a specificity of 75% to 95%, the sensitivity ranged from 49% to 84%. Tumor or patient variables did not influence the results. Conclusions: The TRIMprob™ test was able to provide some degree of discrimination between normal breast tissue and lesions but not between benign and malignant lesions. The lack of influence of patient age and tumor size on test results might be advantageous in terms of early diagnosis in young women. These preliminary results need to be verified and extended in a preclinical-stage disease setting before clinical applicability can be envisaged.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
JournalTumori
Volume92
Issue number3
Publication statusPublished - May 2006

Fingerprint

Electromagnetic Phenomena
Breast Neoplasms
Breast
Area Under Curve
Pathology
Electromagnetic Radiation
Biopsy
Electromagnetic Fields
Mammography
Early Diagnosis
Ultrasonography
Neoplasms
Costs and Cost Analysis
Control Groups

Keywords

  • Biological resonance
  • Breast lesion
  • Electromagnetism (EM)
  • Neoplasm
  • Nonlinear resonance interaction (NLRI)
  • TRIMprob™

ASJC Scopus subject areas

  • Cancer Research

Cite this

Clinical application of spectral electromagnetic interaction in breast cancer : Diagnostic results of a pilot study. / De Cicco, Concetta; Mariani, Luigi; Vedruccio, Clarbruno; Ricci, Carla; Balma, Massimo; Rotmensz, Nicole; Ferrari, Mahila Esmeralda; Autino, Elena; Trifirò, Gluseppe; Sacchini, Virgilio; Viale, Giuseppe; Paganelli, Giovanni.

In: Tumori, Vol. 92, No. 3, 05.2006, p. 207-212.

Research output: Contribution to journalArticle

@article{d92679c6deee41c2a20f7683cc7fd1df,
title = "Clinical application of spectral electromagnetic interaction in breast cancer: Diagnostic results of a pilot study",
abstract = "Aims and background: There is a need for a cost-effective method to safely reduce the number of diagnostic procedures women undergo for breast cancer. We tested a new procedure for breast cancer diagnosis based on breast tissue response to low level electromagnetic incident waves. Methods: We tested 101 patients with suspicious palpable breast lesions detected by mammography or ultrasonography, who were scheduled to undergo an open biopsy. Using an electromagnetic field generator (tissue resonance interaction method probe [TRIMprob™]), we passed the TRIMprob™ over the breast area and recorded the signal variation of one or more spectral lines (dB1, dB2, dB3). The results were compared with those of a control group as well as with pathology data obtained from excisional biopsy. Results: No adverse effects of the test were observed. Pathology revealed 86 malignant breast cancers (72 invasive, 14 in situ) and 15 benign conditions. We achieved the best discrimination between normal breasts and lesions using dB1 (dB1 AUC-ROC = 0.8; dB2 AUC-ROC = 0.61; dB3 AUC-ROC = 0.76). With a specificity of 75{\%} to 95{\%}, the sensitivity ranged from 49{\%} to 84{\%}. Tumor or patient variables did not influence the results. Conclusions: The TRIMprob™ test was able to provide some degree of discrimination between normal breast tissue and lesions but not between benign and malignant lesions. The lack of influence of patient age and tumor size on test results might be advantageous in terms of early diagnosis in young women. These preliminary results need to be verified and extended in a preclinical-stage disease setting before clinical applicability can be envisaged.",
keywords = "Biological resonance, Breast lesion, Electromagnetism (EM), Neoplasm, Nonlinear resonance interaction (NLRI), TRIMprob™",
author = "{De Cicco}, Concetta and Luigi Mariani and Clarbruno Vedruccio and Carla Ricci and Massimo Balma and Nicole Rotmensz and Ferrari, {Mahila Esmeralda} and Elena Autino and Gluseppe Trifir{\`o} and Virgilio Sacchini and Giuseppe Viale and Giovanni Paganelli",
year = "2006",
month = "5",
language = "English",
volume = "92",
pages = "207--212",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Clinical application of spectral electromagnetic interaction in breast cancer

T2 - Diagnostic results of a pilot study

AU - De Cicco, Concetta

AU - Mariani, Luigi

AU - Vedruccio, Clarbruno

AU - Ricci, Carla

AU - Balma, Massimo

AU - Rotmensz, Nicole

AU - Ferrari, Mahila Esmeralda

AU - Autino, Elena

AU - Trifirò, Gluseppe

AU - Sacchini, Virgilio

AU - Viale, Giuseppe

AU - Paganelli, Giovanni

PY - 2006/5

Y1 - 2006/5

N2 - Aims and background: There is a need for a cost-effective method to safely reduce the number of diagnostic procedures women undergo for breast cancer. We tested a new procedure for breast cancer diagnosis based on breast tissue response to low level electromagnetic incident waves. Methods: We tested 101 patients with suspicious palpable breast lesions detected by mammography or ultrasonography, who were scheduled to undergo an open biopsy. Using an electromagnetic field generator (tissue resonance interaction method probe [TRIMprob™]), we passed the TRIMprob™ over the breast area and recorded the signal variation of one or more spectral lines (dB1, dB2, dB3). The results were compared with those of a control group as well as with pathology data obtained from excisional biopsy. Results: No adverse effects of the test were observed. Pathology revealed 86 malignant breast cancers (72 invasive, 14 in situ) and 15 benign conditions. We achieved the best discrimination between normal breasts and lesions using dB1 (dB1 AUC-ROC = 0.8; dB2 AUC-ROC = 0.61; dB3 AUC-ROC = 0.76). With a specificity of 75% to 95%, the sensitivity ranged from 49% to 84%. Tumor or patient variables did not influence the results. Conclusions: The TRIMprob™ test was able to provide some degree of discrimination between normal breast tissue and lesions but not between benign and malignant lesions. The lack of influence of patient age and tumor size on test results might be advantageous in terms of early diagnosis in young women. These preliminary results need to be verified and extended in a preclinical-stage disease setting before clinical applicability can be envisaged.

AB - Aims and background: There is a need for a cost-effective method to safely reduce the number of diagnostic procedures women undergo for breast cancer. We tested a new procedure for breast cancer diagnosis based on breast tissue response to low level electromagnetic incident waves. Methods: We tested 101 patients with suspicious palpable breast lesions detected by mammography or ultrasonography, who were scheduled to undergo an open biopsy. Using an electromagnetic field generator (tissue resonance interaction method probe [TRIMprob™]), we passed the TRIMprob™ over the breast area and recorded the signal variation of one or more spectral lines (dB1, dB2, dB3). The results were compared with those of a control group as well as with pathology data obtained from excisional biopsy. Results: No adverse effects of the test were observed. Pathology revealed 86 malignant breast cancers (72 invasive, 14 in situ) and 15 benign conditions. We achieved the best discrimination between normal breasts and lesions using dB1 (dB1 AUC-ROC = 0.8; dB2 AUC-ROC = 0.61; dB3 AUC-ROC = 0.76). With a specificity of 75% to 95%, the sensitivity ranged from 49% to 84%. Tumor or patient variables did not influence the results. Conclusions: The TRIMprob™ test was able to provide some degree of discrimination between normal breast tissue and lesions but not between benign and malignant lesions. The lack of influence of patient age and tumor size on test results might be advantageous in terms of early diagnosis in young women. These preliminary results need to be verified and extended in a preclinical-stage disease setting before clinical applicability can be envisaged.

KW - Biological resonance

KW - Breast lesion

KW - Electromagnetism (EM)

KW - Neoplasm

KW - Nonlinear resonance interaction (NLRI)

KW - TRIMprob™

UR - http://www.scopus.com/inward/record.url?scp=33746268364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746268364&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 207

EP - 212

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -